Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: Avoiding a serious adverse drug interaction

Brad Moriyama, Oluwaseun Falade-Nwulia, Janice Leung, Scott R. Penzak, Caroline Jjingo, Xuan Huang, Stacey A. Henning, Wyndham H. Wilson, Thomas J. Walsh

Research output: Contribution to journalLetter

13 Scopus citations

Fingerprint Dive into the research topics of 'Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: Avoiding a serious adverse drug interaction'. Together they form a unique fingerprint.